These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 9039923
21. Prolongation of renal allograft survival in antilymphocyte-serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow. Hartner WC, De Fazio SR, Maki T, Markees TG, Monaco AP, Gozzo JJ. Transplantation; 1986 Dec; 42(6):593-7. PubMed ID: 2947358 [Abstract] [Full Text] [Related]
23. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine. Hartner WC, Van der Werf WJ, Lodge JP, Gilchrist B, De Fazio SR, Markees TG, Yatko C, Monaco AP, Gozzo JJ. Transplantation; 1995 Dec 15; 60(11):1347-50. PubMed ID: 8525533 [Abstract] [Full Text] [Related]
24. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells. De Fazio S, Hartner WC, Monaco AP, Gozzo JJ. J Immunol; 1985 Nov 15; 135(5):3034-8. PubMed ID: 2864375 [Abstract] [Full Text] [Related]
29. Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells. Umemura A, Monaco AP, Maki T. Transplantation; 2000 Oct 15; 70(7):1005-9. PubMed ID: 11045634 [Abstract] [Full Text] [Related]
30. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. Khanna A, Steptoe RJ, Antonysamy MA, Li W, Thomson AW. Transplantation; 1998 Feb 27; 65(4):479-85. PubMed ID: 9500620 [Abstract] [Full Text] [Related]
31. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. Antonysamy MA, Steptoe RJ, Khanna A, Rudert WA, Subbotin VM, Thomson AW. J Immunol; 1998 Apr 15; 160(8):4106-13. PubMed ID: 9558122 [Abstract] [Full Text] [Related]
34. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine. Hale DA, Gottschalk R, Wood ML, Maki T, Monaco AP. Transplant Proc; 1996 Dec 15; 28(6):3270-1. PubMed ID: 8962270 [No Abstract] [Full Text] [Related]
35. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice. Wood ML, Gottschalk R, Monaco AP. Transplantation; 1980 Apr 15; 29(4):320-3. PubMed ID: 6445103 [Abstract] [Full Text] [Related]
38. Prolongation of adult skin allograft survival by cotransplantation of neonatal skin in antilymphocyte serum and donor bone marrow cell-treated mice. Markees TG, De Fazio SR, Gozzo JJ. Transplantation; 1990 Dec 15; 50(6):911-4. PubMed ID: 2256160 [Abstract] [Full Text] [Related]